DRW Securities’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

DRW Securities’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-42,719	Closed	-$4.22M	–	805
2024 Q3	$4.22M	Buy	42,719 +27,789	+186%	+$2.73M	0.12%	103
2024 Q2	$1.38M	Buy	+14,930	New	+$1.34M	0.05%	195
2023 Q3	–	Sell	-40,500	Closed	-$3.37M	–	474
2023 Q2	$3.37M	Buy	40,500 +37,824	+1,413%	+$3.16M	0.08%	78
2023 Q1	$204K	Buy	+2,676	New	+$222K	﹤0.01%	294
2013 Q3	–	Sell	-59,538	Closed	-$2.07M	–	264
2013 Q2	$2.07M	Buy	+59,538	New	+$2.09M	0.08%	52

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

DRW Securities's XBI Position: Q4 2024 in Review

DRW Securities sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2024, closing a stake of 42,719 shares — an estimated $4.22M sold.

DRW Securities first reported a position in XBI in Q2 2013 and held it in 5 quarters. The position peaked at $4.22M in Q3 2024. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.

DRW Securities reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2024 after selling out during the quarter.
DRW Securities sold 42,719 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $4.22M.
DRW Securities first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and held it in 5 quarters.
DRW Securities's State Street SPDR S&P Biotech ETF position peaked at $4.22M in Q3 2024.
738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.

Based on DRW Securities's 13F filing for Q4 2024, filed 13 Feb 2025.